Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment

基金名称
Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment
资助机构
National Institute of Mental Health (NIMH)
National Institutes of Health (NIH)
United States Department of Health and Human Services (HHS)
地区
United States
研究领域
Discrimination
Health Disparities
HIV/AIDS
Minorities and Disadvantaged
截止日期
September 7, 2022 (已过期)
联系方式
Gregory Greenwood, PhD, MPH, Scientific/Research Contact gregory.greenwood@nih.gov
Rita Sisco, Financial/Grants Management Contact rita.sico@mail.gov
基金编号
NOT-MH-20-020
说明
This Notice calls for research on understanding and addressing the impact of stigma or other social determinants of health as they relate to HIV prevention and treatment for socially disadvantaged populations.Stigma and other social determinants of health, that is, those social conditions and economic circumstances that influence health, are known barriers to HIV prevention and HIV treatment. For example, stigma related to HIV or other intersecting forces of discrimination or disadvantage (intersectional stigma or intersectional discrimination), socio-economic factors such as homelessness, lack of employment and having no high school education are all associated with increased risk of HIV in cities or regions with high HIV/AIDS prevalence. Remaining in school is associated with delayed sexual debut and potentially reduces risk of HIV acquisition among young girls in Sub-Saharan Africa. The mechanisms through which stigma and other social determinants exert their effect may include but are not limited to the following multi-level factors: social/interpersonal (e.g., social capital, social cohesion, culture), and systems/community (e.g., unemployment, legislation, access to health care, institutionalized racism, policies). Keywords Discrimination Health Disparities HIV/AIDS Minorities and Disadvantaged Upcoming Deadlines NoteSubmit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.PA-20-144PA-20-145PA-20-141PA-19-126PA-19-127PA-19-116PA-19-117PA-19-118PA-19-119PA-19-052PA-19-129PA-19-130PA-19-121PA-19-122PA-19-272PA-19-273PA-19-270PA-19-271PAR-19-051PAR-19-098PAR-17-485PAR-18-714PAR-19-133PAR-19-134PAR-19-135PAR-19-283PA-19-192PA-19-195PA-19-196PA-19-188PA-18-403 Recurrence of Opportunity:This is a one-off opportunity. We do not expect future rounds.

基金资源

NIMH Grant Writing & Approval Process 打开链接
Purdue Grant Writing Lab: Introduction to Grant Writing 打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal 打开链接

快速分享


将截止日期添加到日历

September 7, 2022

你有想要在此列出的基金申报机会吗?

立即提交你的基金合作意向,发送至 support@peeref.com,我们会尽快为你审核。


Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

相关基金

International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
European Partnership: One Health Anti-Microbial Resistance
Antimicrobial resistance 2024-09-25 €100000000
NIOSH Centers for Agricultural Safety and Health
Health Dec 01, 2024 12:00:00 AM EST $2,200,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): MOMENTUM Monitoring and evaluation, knowledge management and translation
Medicine September 30, 2025 Up to 25,000,000 USD
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): Targeted MNCH/FP/RH technical assistance to private providers
Medicine September 30, 2025 Up to 75,000,000 USD
Innovative Health Practices
Science and Technology and other Researc... Feb 20, 2028 12:00:00 AM EST $1,000,000,000